Literature DB >> 25914355

Aortic annulus and root characteristics in severe aortic stenosis due to bicuspid aortic valve and tricuspid aortic valves: implications for transcatheter aortic valve therapies.

Femi Philip1, Nadine Nadar Faza1, Paul Schoenhagen1, Milind Y Desai1, E Murat Tuzcu1, Lars G Svensson1, Samir R Kapadia1.   

Abstract

BACKGROUND: Patients with severe aortic stenosis due to BAV are excluded from transcatheter aortic valve replacement (TAVR) due to concern for asymmetric expansion and valve dysfunction. We sought to characterize the aortic root and annulus in bicuspid aortic valve (BAV) and tricuspid aortic valves (TAV). METHODS AND
RESULTS: We identified patients with severe AS who underwent multi-detector computed tomographic (MDCT) imaging prior to surgical aortic valve replacement (SAVR, n = 200) for BAV and TAVR (n = 200) for TAV from 2010 to 2013. The presence of a BAV was confirmed on surgical and pathological review. Annulus measurements of the basal ring (short- and long-axis, area-derived diameter), coronary ostia height, sinus area (SA), sino-tubular junction area (STJ), calcification and eccentricity index (EI, 1-short axis/long axis) were made. Patients with TAV were older (78.8 years vs. 57.8 years, P = 0.04) than those with BAV. The aortic annulus area (5.21 ± 2.1 cm(2) vs. 4.63 ± 2.0 cm(2) , P = 0.0001), sinus of Valsalva diameter (3.7 ± 0.9 cm vs. 3.1 ± 0.1 cm, P = 0.001) and ascending aorta diameter (3.5 ± 0.7 cm vs. 2.97 ± 0.6 cm, P = 0.001) were significantly larger with BAV. Bicuspid aortic annuli were significantly less elliptical (EI, 1.24 ± 0.1 vs. 1.29 ± 0.1, P = 0.006) and more circular (39% vs. 4%, P < 0.001) compared to the TAV annulus. There was more eccentric annular calcification in BAV vs. TAV (68% vs. 32%, P < 0.001). The mean distance from the aortic annulus to the left main coronary ostium was less than the right coronary ostium. Less than 10% of the BAV annuli would not fit a currently available valved stents.
CONCLUSION: Bicuspid aortic valves have a larger annulus size, sinus of Valsalva and ascending aorta dimensions. In addition, the BAV aortic annuli appear circular and most will fit currently available commercial valved stents.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  aortic valve disease; percutaneous intervention; percutaneous valve therapy; structural heart disease intervention

Mesh:

Year:  2015        PMID: 25914355     DOI: 10.1002/ccd.25948

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  22 in total

Review 1.  Transcatheter aortic valve replacement in patients with bicuspid aortic valves.

Authors:  Amisha Patel; Martin B Leon
Journal:  J Thorac Dis       Date:  2018-11       Impact factor: 2.895

Review 2.  Aortic annulus sizing in stenotic bicommissural non-raphe-type bicuspid aortic valves: reconstructing a three-dimensional structure using only two hinge points.

Authors:  Antonio H Frangieh; Jonathan Michel; Oliver Deutsch; Michael Joner; Costanza Pellegrini; Tobias Rheude; Sabine Bleiziffer; Albert Markus Kasel
Journal:  Clin Res Cardiol       Date:  2018-06-14       Impact factor: 5.460

3.  Characteristics of aorto-iliofemoral arterial tree according to aortic valve morphology in chinese patients considered for TAVR.

Authors:  Yuan Wang; Hasan Jilaihawi; Guanyuan Song; Moyang Wang; Bin Lv; Hao Wang; Guannan Niu; Zheng Zhou; Yongjian Wu
Journal:  Int J Cardiovasc Imaging       Date:  2018-02-02       Impact factor: 2.357

4.  Long-Term Mortality After TAVI for Bicuspid vs. Tricuspid Aortic Stenosis: A Propensity-Matched Multicentre Cohort Study.

Authors:  Aleksandra Gasecka; Michał Walczewski; Adam Witkowski; Maciej Dabrowski; Zenon Huczek; Radosław Wilimski; Andrzej Ochała; Radosław Parma; Piotr Scisło; Bartosz Rymuza; Karol Zbroński; Piotr Szwed; Marek Grygier; Anna Olasińska-Wiśniewska; Dariusz Jagielak; Radosław Targoński; Grzegorz Opolski; Janusz Kochman
Journal:  Front Cardiovasc Med       Date:  2022-06-21

5.  A Glimpse into the Future: In 2020, Which Patients will Undergo TAVI or SAVR?

Authors:  Crochan J O'Sullivan; Peter Wenaweser
Journal:  Interv Cardiol       Date:  2017-05

Review 6.  Comparing outcomes after transcatheter aortic valve replacement in patients with stenotic bicuspid and tricuspid aortic valve: A systematic review and meta-analysis.

Authors:  Napatt Kanjanahattakij; Benjamin Horn; Wasawat Vutthikraivit; Sylvia Marie Biso; Mary Rodriguez Ziccardi; Marvin Louis Roy Lu; Pattara Rattanawong
Journal:  Clin Cardiol       Date:  2018-07-18       Impact factor: 2.882

7.  Outcomes of transcatheter aortic valve replacement in bicuspid aortic valve stenosis.

Authors:  Tamunoinemi Bob-Manuel; Mark R Heckle; Ikechukwu A Ifedili; Jiajing Wang; Uzoma N Ibebuogu
Journal:  Ann Transl Med       Date:  2019-03

8.  KPT-330 Prevents Aortic Valve Calcification via a Novel C/EBPβ Signaling Pathway.

Authors:  Punashi Dutta; Karthik M Kodigepalli; Stephanie LaHaye; J Will Thompson; Sarah Rains; Casey Nagel; Kaitlyn Thatcher; Robert B Hinton; Joy Lincoln
Journal:  Circ Res       Date:  2021-02-19       Impact factor: 17.367

9.  Safety and efficacy of minimalist transcatheter aortic valve implantation using a new-generation balloon-expandable transcatheter heart valve in bicuspid and tricuspid aortic valves.

Authors:  Jonathan M Michel; Antonio H Frangieh; Daniele Giacoppo; Hector A Alvarez-Covarrubias; Costanza Pellegrini; Tobias Rheude; Oliver Deutsch; N Patrick Mayr; P Moritz Rumpf; Barbara E Stähli; Adnan Kastrati; Heribert Schunkert; Erion Xhepa; Michael Joner; A Markus Kasel
Journal:  Clin Res Cardiol       Date:  2021-09-09       Impact factor: 5.460

Review 10.  Impact of Valve Morphology on the Prevalence of Coronary Artery Disease: A Systematic Review and Meta-Analysis.

Authors:  Paolo Poggio; Laura Cavallotti; Paola Songia; Alessandro Di Minno; Pasquale Ambrosino; Liborio Mammana; Alessandro Parolari; Francesco Alamanni; Elena Tremoli; Matteo Nicola Dario Di Minno
Journal:  J Am Heart Assoc       Date:  2016-05-18       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.